
Please try another search
IPO Listing | Company | Exchange | IPO Value | IPO Price | Last |
---|---|---|---|---|---|
IPO Listing | Company | Exchange | IPO Value | IPO Price | Last |
Feb 19, 2025 | Anbio Biotechnology Inc (NNNN) | NASDAQ | 8.0M | 5.00 | 6.69 |
Feb 20, 2025 | Nusatrip Inc (NUTR) | NASDAQ | 10.8M | 4.00 | 41.80 |
Feb 21, 2025 | Wellgistics Health Inc (WGRX) | NASDAQ | 4.1M | 4.50 | 2.70 |
Feb 23, 2025 | Apimeds Pharma US Ltd (APUS) | NYSE | 22.5M | 4.00-5.00 | 4.50 |
Feb 25, 2025 | Basel Medical Group (BMGL) | NASDAQ | 11.0M | 4.00 | 4.17 |
Feb 27, 2025 | Luda Tech Group Ltd (LUD) | NASDAQ | 10.0M | 4.00 | 4.06 |
Feb 27, 2025 | Lz Technology Holdings Corp (LZMH) | NASDAQ | 7.2M | 4.00 | 5.65 |
Feb 27, 2025 | Webus International Ltd (WETO) | NASDAQ | 8.0M | 4.00 | 3.76 |
Feb 28, 2025 | Fifth Era Acq I Corp (FERAU) | NASDAQ | 200.0M | 10.00 | 10.02 |
Feb 28, 2025 | Live Oak Acq V Corp (LOKVU) | NASDAQ | 200.0M | 10.00 | 10.02 |
Feb 28, 2025 | Rithm Acquisition Corp (RAC_u) | NYSE | 10.00 | 10.03 | |
Feb 28, 2025 | Scottish Oriental Small Co Trust Plc (SOST) | London | - | 286.19 | |
Feb 28, 2025 | JPMorgan Global Core Real Assets Ltd (JARA) | London | 100.00 | 84.40 |
Singapore, March 03, 2025 (GLOBE NEWSWIRE) -- Basel Medical (TASE:BLWV) Group Ltd (the Company) (Nasdaq: BMGL), a Singapore-based clinical provider of general and...
HUZHOU CITY, China, Feb. 28, 2025 (GLOBE NEWSWIRE) -- LZ Technology Holdings Limited (NASDAQ: LZMH) (LZ Technology or the Company), an information technology and advertising...
Basel Medical Group Ltd (Nasdaq: BMGL), a Singapore-based clinical provider of general and subspecialized orthopedic and trauma services, sports medicine and surgery, orthopedic...
Singapore, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Basel Medical (TASE:BLWV) Group Ltd (the Company) (Nasdaq: BMGL), a Singapore-based clinical provider of general and...
Frankfurt am Main, Germany, Feb. 20, 2025 (GLOBE NEWSWIRE) -- Anbio Biotechnology (the Company or Anbio), a global diagnostic company dedicated to the advancement of medical...
Investing.com -- Anbio Biotechnology, a global diagnostic company, announced the pricing of its initial public offering (IPO) at $5.00 per Class A Ordinary Share. However, the...
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Technology, Utilities and Industrials sectors propelled shares higher. At the close in NYSE, the...